Jatinder Kaur Mukker, PhD

Director, Clinical Pharmacology
EMD Serono, Billerica, MA, USA

Poster(s):

• (T-063) Advancing Modeling of Hematologic Safety using a Semi-mechanistic Multivariate PK/PD Approach: Application to the ATR Inhibitor Tuvusertib in Early Phase Oncology Development
  Tuesday, November 12, 2024

  7:00 AM – 5:00 PM MST